Article
Congenital Myasthenic Syndromes in Turkey: Clinical and Molecular Characterization of 16 Cases With Three Novel Mutations.
Pediatric neurology - 1 Nov 2022
Öztürk Selcan, Güleç Ayten, Erdoğan Murat, Demir Mikail, Canpolat Mehmet, Gümüş Hakan, Çağlayan Ahmet Okay, Dündar Munis, Per Hüseyin
Abstract excerpt
BACKGROUND: Congenital myasthenic syndromes (CMS) are composed of numerous hereditary disorders involving genetic mutations in proteins essential to the integrity of neuromuscular transmission. The symptoms of CMS vary according to the age at onset of symptoms, and the type and severity of muscle weakness. Effective treatment and genetic counseling depend upon the underlying pathogenic molecular mechanism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
